- 8 February 2019
- Transport / Logistics Services
UPS owned specialist delivery firm Marken is to expand its Philadelphia unit to include more space for logistic operations and a Good Manufacturing Practice (GMP) complaint storage and distribution centre to meet increased local demand.
The new GMP facility is built around clinical drug handling and thanks to its proximity to Philadelphia International Airport allows for faster transit times. Marken’s 11,000 square foot depot is to be connected to the existing logistics hub and will offer temperature controlled capabilities, including storage for +2 to +8⁰C, +15 to +15⁰C and -20⁰C, limited packaging and labeling services. There are also plans to develop future storage for genetically modified organisms (GMO) to meet the increased demand in cell and gene therapies.
The newly expanded Marken depot is also to have central pharmacy capabilities in the GMP unit. According to the company, “This additional service will be aligned with Marken’s strategy to focus on patient centricity which includes direct to / from patient home deliveries and home health care services.”
The new logistics operations site will double the site’s current size and allow for managing pallet shippers and active containers, conditioning temperature controlled shippers and warehouse storage. The new space will also increase the capacity of its 24/7 Patient Communications Center (PCC) to assist patients who participate in trials from their homes.
Wes Wheeler, CEO of Marken, said, “The new and expanded space in Philadelphia will allow synergies between our key operating branch in Philadelphia and a new GMP depot / distribution center. We will be able to provide all of our clinical logistics services under one roof, ensuring streamlined and efficient solutions for our clients. It is Marken’s strategy and ultimate goal to create a complete end-to-end supply chain featuring: logistics, customer service, storage, distribution and labelling services from each of our global GMP locations.”